ADIPOQ and Alzheimer disease: Many studies have indicated that alteration levels of adiponectin in the plasma and cerebrospinal fluid (CSF) correspond to a distinctive condition of mild cognitive impairment (MCI) and AD [8,9,10,11,12,13].